Journal of Natural Medicines

, Volume 67, Issue 3, pp 636–642 | Cite as

Anti-influenza virus activity of Ginkgo biloba leaf extracts

  • Takahiro Haruyama
  • Kyosuke NagataEmail author
Original Paper


We examined the influence of Ginkgo biloba leaf extract (EGb) on the infectivity of influenza viruses in Madin–Darby canine kidney (MDCK) cells. Plaque assays demonstrated that multiplication of influenza viruses after adsorption to host cells was not affected in the agarose overlay containing EGb. However, when the viruses were treated with EGb before exposure to cells, their infectivity was markedly reduced. In contrast, the inhibitory effect was not observed when MDCK cells were treated with EGb before infection with influenza viruses. Hemagglutination inhibition assays revealed that EGb interferes with the interaction between influenza viruses and erythrocytes. The inhibitory effect of EGb was observed against influenza A (H1N1 and H3N2) and influenza B viruses. These results suggest that EGb contains an anti-influenza virus substance(s) that directly affects influenza virus particles and disrupts the function of hemagglutinin in adsorption to host cells. In addition to the finding of the anti-influenza virus activity of EGb, our results demonstrated interesting and important insights into the screening system for anti-influenza virus activity. In general, the plaque assay using drug-containing agarose overlays is one of the most reliable methods for detection of antiviral activity. However, our results showed that EGb had no effects either on the number of plaques or on their sizes in the plaque assay. These findings suggest the existence of inhibitory activities against the influenza virus that were overlooked in past studies.


Antiviral effect Ginkgo biloba leaf extract Hemagglutination Influenza virus 



We thank Katsushi Ogami and Yasuyuki Oku (Mitsubishi Paper Mills Ltd.) and Dr. Eri Nobusawa (Nagoya City University) for providing us with EGb and influenza B/Lee/40 viruses, respectively. We also thank Flaminia Miyamasu (Medical English Communication Center of Faculty of Medicine) for proofreading of this manuscript. This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KN) and a Grant for the project of Tsukuba Industrial Liaison and Cooperative Research (KN).


  1. 1.
    Chan PC, Xia Q, Fu PP (2007) Ginkgo biloba leave extract: biological, medicinal, and toxicological effects. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 25:211–244PubMedCrossRefGoogle Scholar
  2. 2.
    DeFeudis FV, Drieu K (2000) Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 1:25–58PubMedCrossRefGoogle Scholar
  3. 3.
    Diamond BJ, Shiflett SC, Feiwel N, Matheis RJ, Noskin O, Richards JA, Schoenberger NE (2000) Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil 81:668–678PubMedGoogle Scholar
  4. 4.
    Drieu K (1986) Preparation and definition of Ginkgo biloba extract. Presse Med 15:1455–1457PubMedGoogle Scholar
  5. 5.
    Lichtblau D, Berger JM, Nakanishi K (2002) Efficient extraction of ginkgolides and bilobalide from Ginkgo biloba leaves. J Nat Prod 65:1501–1504PubMedCrossRefGoogle Scholar
  6. 6.
    Long JK, Mossad SB, Goldman MP (2000) Antiviral agents for treating influenza. Cleve Clin J Med 67:92–95PubMedGoogle Scholar
  7. 7.
    Miki K, Nagai T, Suzuki K, Tsujimura R, Koyama K, Kinoshita K, Furuhata K, Yamada H, Takahashi K (2007) Anti-influenza virus activity of biflavonoids. Bioorg Med Chem Lett 17:772–775PubMedCrossRefGoogle Scholar
  8. 8.
    Mori K, Haruyama T, Nagata K (2011) Tamiflu-resistant but HA-mediated cell-to-cell transmission through apical membranes of cell-associated influenza viruses. PLoS ONE 6(11):e28178PubMedCrossRefGoogle Scholar
  9. 9.
    Nagata K, Sakagami H, Harada H, Nonoyama M, Ishihama A, Konno K (1990) Inhibition of influenza virus infection by pine cone antitumor substances. Antivir Res 13:11–21PubMedCrossRefGoogle Scholar
  10. 10.
    Nakayama M, Suzuki K, Toda M, Okubo S, Hara Y, Shimamura T (1993) Inhibition of the infectivity of influenza virus by tea polyphenols. Antivir Res 21:289–299PubMedCrossRefGoogle Scholar
  11. 11.
    Regoes RR, Bonhoeffer S (2006) Emergence of drug-resistant influenza virus: population dynamical considerations. Science 312:389–391PubMedCrossRefGoogle Scholar
  12. 12.
    Song J, Lee K, Seong B (2005) Antiviral effect of catechins in green tea on influenza virus. Antivir Res 68:66–74PubMedCrossRefGoogle Scholar
  13. 13.
    Turan K, Nagata K, Kuru A (1996) Antiviral effect of Sanicula europaea L. leaves extract on influenza virus-infected cells. Biochem Biophys Res Commun 225:22–26PubMedCrossRefGoogle Scholar
  14. 14.
    Wang X, Jia W, Zhao A, Wang X (2006) Anti-influenza agents from plants and traditional Chinese medicine. Phytother Res 20:335–341PubMedCrossRefGoogle Scholar
  15. 15.
    Watanabe K, Momose F, Handa H, Nagata K (1995) Interaction between influenza virus proteins and pine cone antitumor substance that inhibits the virus multiplication. Biochem Biophys Res Commun 214:318–323PubMedCrossRefGoogle Scholar
  16. 16.
    Wiley DC, Skehel JJ (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56:365–394PubMedCrossRefGoogle Scholar
  17. 17.
    Yoshikawa T, Naito Y, Kondo M (1999) Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxid Redox Signal 1:469–480PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society of Pharmacognosy and Springer Japan 2012

Authors and Affiliations

  1. 1.Department of Infection Biology, Faculty of Medicine and Graduate School of Comprehensive Human SciencesUniversity of TsukubaTsukubaJapan
  2. 2.Research CenterAVSS CorporationNagasakiJapan

Personalised recommendations